The IMpassion130 Study in Metastatic TNBC Published 2018-12-27 Download video MP4 360p Recommendations 08:38 Comprehensive Anticoagulation Management for VTE 01:58 CheckMate-9ER Proves to be Efficacious in Advanced or Metastatic RCC 04:30 Sequencing Novel Therapies in Colorectal Cancer 02:51 IMpassion130: Design and Preliminary Efficacy 16:01 What is inflammatory breast cancer? Patient Jennifer Cordts talks with Dr. Joyce O’Shaughnessy 03:59 Health Information Technology & Management at Parker University | Good Morning Texas 02:41 Get a More Focused Mind with the 2+5+7 Formula 04:48 Are Oxybates Safe in Narcolepsy Patients? 24:06 Children of Narcissistic Parents 01:31 Exploring the Tazemetostat Approval in R/R Follicular Lymphoma 32:17 Female Bladder Leakage: Solutions to Get Control | Christopher Tarnay, MD | UCLAMDChat 03:47 Dr. Maas on Sleeping for Success | The Center for BrainHealth® 47:34 Enhancing Brain Tumor Treatment with Clinical Trials: Dr. Yoshie Umemura 01:47 Biomarker Testing Varies at Community/Academic Centers for Gastric Cancer 01:30 Go Red For Women® | Open Your Heart 01:37 Immunotherapy Combinations Improve Survival in Advanced Renal Cell Carcinoma 06:37 Advanced Adenomas and Increased Risk of Colorectal Cancer Development and Mortality 12:37 2020 Caitlin Baran Giving Tuesday Interview 08:45 Developing COVID-19 Science in Real Time | What to Know | WTK 01:37 TRK Fusions Help to Fulfill Unmet Need in Thyroid Cancer Treatment Landscape Similar videos 01:16 The IMpassion130 Trial in Metastatic Triple-Negative Breast Cancer 06:33 Case 3: Results of the IMpassion130 Trial in Metastatic Breast Cancer 07:19 IMpassion130 Trial: OS Updates in Metastatic TNBC 02:33 Applying IMpassion130 Data to TNBC Management 07:40 Study of Carboplatin plus Nivolumab in Metastatic Triple-Negative Breast Cancer 04:47 TNBC: Updated Efficacy Results From IMpassion130 02:30 IMpassion130: immunotherapy for TNBC 06:56 IMpassion130 Trial Data on PD-L1+ Tumors in TNBC 01:55 Sara M. Tolaney, MD, MPH, shares outcomes from the ImPassion130 study in TNBC 02:52 IMpassion130 study: improvement in OS and PFS for IIT and PD-L1+ populations with mTNBC 04:11 Immunotherapy for TNBC: IMpassion130 & KEYNOTE-355 08:42 Chemoimmunotherapy in TNBC: The IMpassion130 Trial 04:53 Results from the IMpassion130 trial for triple-negative breast cancer 04:56 Results from the IMpassion 130 trial treating metastatic breast cancer 05:59 IMpassion130: Atezolizumab and nab-paclitaxel in triple-negative breast cancer 07:08 IMpassion130: results of atezolizumab plus nab-paclitaxel for frontline TNBC 07:36 ESMO 2020 Expert Video report on atezolizumab in upfront treatment of TNBC 01:44 Debu Tripathy, MD, elaborates on outcomes from the ImPassion130 trial More results